Alan M. Kirschenbaum

Mr. Kirschenbaum has been in private practice since 1990 representing pharmaceutical and medical device companies in matters relating to the Food and Drug Administration and other areas of health care law. His practice focuses on drug and device promotion, marketing, contracting, and pricing, as these activities are affected by FDA restrictions on promotion, health care fraud and abuse laws, and government discount and price reporting requirements. He has authored articles and given frequent lectures on legal issues relating to pharmaceutical and medical device promotion and marketing activities. He is a member of the D.C. Bar Health Law Section and former member of that Section's Steering Committee, and also a member of the American Health Lawyers Association.

Mr. Kirschenbaum received his undergraduate degree cum laude from the University of Pennsylvania in 1970 and his law degree cum laude from Harvard Law School in 1986. He served as a law clerk for Judge Theodore R. Newman of the District of Columbia Court of Appeals from 1986 through 1987. He is admitted to practice in the District of Columbia and Maryland.

Good to know

Areas of Practice 1) Healthcare and 2) Food and Drug Administration
Law School Harvard Law School
Education University of Pennsylvania
Bar Member / Association District of Columbia, State Bar of Maryland
Most recent firm Hyman, Phelps & McNamara P.C.
Barbara A. Fitzgerald
Barbara A. Fitzgerald

Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.

Barbara J. Shander
Barbara J. Shander

Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.

Brian M. Jazaeri
Brian M. Jazaeri

Brian M. Jazaeri is a partner in Morgan Lewis's Litigation Practice. Mr. Jazaeri represents clients in complex commercial litigation, with a particular emphasis on class action matters and financial services, healthcare and technology litigation.